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Haemophilus ducreyi is a strict human pathogen that causes sexually transmitted genital ulcer disease. We
infected domestic swine with H. ducreyi 35000, resulting in the development of cutaneous ulcers histologically
resembling human chancroid lesions. Intraepidermal lesions progressed from pustules to ulcers containing
polymorphonuclear leukocytes and were accompanied by a dermal inflammatory infiltrate containing T cells
and macrophages. H. ducreyi was recovered from lesions up to 17 days after inoculation, and pigs did not
develop immunity to reinfection with the challenge strain. Features of the model include inoculation through
abrasions in the epidermis, ambient housing temperatures for infected pigs, the ability to deliver multiple
different inocula to a single host, and the availability of monoclonal antibodies against porcine immune cells
permitting immunohistochemical characterization of the host immune response to H. ducreyi infection.
Chancroid, an ulcerating cutaneous infection caused byHae-
mophilus ducreyi, is one of the most prevalent sexually trans-
mitted diseases in developing countries (12, 34, 39) and is
endemic in some areas of the United States (3, 5, 14, 31). H.
ducreyi infection is a recognized cofactor for transmission of
the human immunodeficiency virus (29, 37, 38, 40), making it
the focus of considerable recent research aimed at understand-
ing the molecular mechanisms of pathogenesis of this organ-
ism.
Potential H. ducreyi virulence factors include lipo-oligosac-
charide (2, 10), pili (11, 50), and the production of extracellular
cytotoxin(s) (27, 28, 42). The importance of these and other
bacterial determinants in ulcer formation, and their roles in
pathogenesis, may best be understood by using genetically de-
fined mutant strains of H. ducreyi in an animal model of infec-
tion. Several models including the use of rabbits (41), humans
(52) and primates (53) have been described, but each has
limitations, ranging from artificial housing conditions and in-
oculation procedures for rabbits to the high cost of primates.
In addition, ethical concerns preclude allowing the progression
of lesions to the ulcerative stage in human volunteers, and the
use of antibiotic-resistant bacteria in humans is prohibited
under many circumstances.
H. ducreyi is primarily a cutaneous pathogen; while involve-
ment of regional lymph nodes is not uncommon in chancroid,
H. ducreyi is seldom recovered from bubo aspirates (25), and
the bacteria do not invade deeper tissue or cause systemic
disease (34). Because the skin of juvenile pigs closely resem-
bles human skin both structurally and physiologically (6, 13, 23,
26, 32, 55, 56), we investigated the ability of H. ducreyi to cause
dermal lesions in swine. Lesions histologically resembling nat-
ural human chancres developed in pig skin following inocula-
tion through abrasions in the epithelium, providing a useful
animal model for the study of H. ducreyi pathogenesis and host
response to infection.
MATERIALS AND METHODS
Animals. Crossbred (Yorkshire, Landrace, Hampshire, and Duroc Cross) or
purebred (Landrace) conventionally reared swine were obtained at weaning (3
weeks old) and housed at ambient temperatures (20 to 258C) in AAALAC-
accredited P2 containment facilities at the North Carolina State University
College of Veterinary Medicine. Pigs received water and an antibiotic-free,
high-protein growth ration (77% corn meal, 21% soybean meal, 2% of a mineral
and vitamin mixture) ad libitum for a minimum of 3 weeks prior to inoculation
and throughout the period of infection with H. ducreyi. For inoculation and
biopsy procedures, 6- to 10-week-old animals were sedated with approximately 2
mg each of ketamine HCl (Fort Dodge Laboratories, Fort Dodge, Iowa) and
xylazine (Miles Laboratories, Shawnee Mission, Kans.) per kg of body weight
administered intravenously. After inoculation, the pigs were kept in individual
enclosures and observed daily for the first week and every 3 to 7 days thereafter.
Inoculum preparation. Stock cultures of H. ducreyi 35000 (ATCC 33922) were
maintained at 2808C as described previously (10) and grown on chocolate agar
plates (Difco GC agar base, 1% IsoVitaleX [Becton Dickinson, Cockeysville,
Md.], 1% hemoglobin) with or without 3 mg of vancomycin per ml at 358C in a
humidified atmosphere with 5% CO2. Cultures from frozen stocks were plated
on chocolate agar, grown for 24 h, and passaged once onto fresh plates to obtain
confluent 24-h growth for inoculation. H. ducreyi bacteria were scraped from two
to three plates with wooden applicator sticks and suspended in 1 ml of sterile
phosphate-buffered saline (PBS). Bacterial suspensions yielded between 5 3 108
and 3.2 3 109 [mean 5 (1.4 6 1.2) 3 109] CFU/ml on the basis of duplicate
cultures of serial 10-fold dilutions. Solutions of H. ducreyi, particularly when
prepared from plate-grown organisms, are difficult to quantitate accurately be-
cause the bacteria form clumps that cannot be dispersed uniformly. Therefore,
the measurement of CFU per milliliter represents only an estimate of the actual
concentration of viable H. ducreyi. Portions of the inoculum were killed by
heating in a boiling water bath for 5 min. No H. ducreyi CFU were recovered
from 100 ml of this suspension plated on chocolate agar.
Inoculation. For inoculation of pig ears, hair was shaved from the dorsal
surface, when necessary, with a disposable razor. The skin was cleansed with 95%
ethanol and allowed to dry. For inoculation on backs, hair was first removed with
standard veterinary clippers, and then the back was shaved and cleansed as
described above. We inoculated 10 ml of bacterial suspension containing approx-
imately 107 CFU of live or heat-killed H. ducreyi onto prepared skin with a
Multi-Test Applicator (Lincoln Diagnostics, Decatur, Ill.) as described by Spi-
nola et al. (52). Each of the eight pads of the Multi-Test device contains an array
(2 by 2 mm) of nine individual tines that penetrate approximately 2 mm when
applied as described in the manufacturer’s directions. Droplets were absorbed
occasionally into the skin during the brief period of observation immediately
after application, but frequently, beads of PBS remained on the surface of the
skin at least 30 min after inoculation when the animals were beginning to regain
consciousness. Visible clumps of H. ducreyi consistently remained lodged be-
tween the tines of the application device after inoculation of both live and
heat-killed inocula. Undelivered material remained even after vigorous rinsing
with PBS, precluding an accurate determination of the fraction of H. ducreyi
loaded onto the device that was actually delivered to the pig skin.
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Biopsy and sample preparation. Lesion biopsies were done with a 6-mm
disposable skin punch (Acuderm, Ft. Lauderdale, Fla.), and the samples were cut
in half. For recovery of H. ducreyi, sample halves were placed in brain heart
infusion broth (Difco Laboratories, Detroit, Mich.) containing 10% fetal calf
serum (HyClone Laboratories, Inc., Logan, Utah) 1% IsoVitaleX, and 50 mg of
hemin per ml or 10 mg of hemoglobin per ml and transported to the laboratory.
Specimens were minced with sterile scalpel blades and cultured on chocolate
agar plates. H. ducreyi organisms recovered from lesions were identified by their
distinctive colony morphology and resistance to 3 mg of vancomycin per ml.
Samples for routine histology were fixed in 10% formalin and embedded in
paraffin. Thin sections were stained with hematoxylin-eosin (H&E), Giemsa, or
Warthin-Starry (tissue silver stain) reagents by standard procedures. Specimens
were evaluated independently by a dermatologist specializing in histopathology
and a veterinary pathologist.
For immunohistochemistry, the tissue was frozen on dry ice immediately after
biopsy and maintained at 2808C until 10-mm sections were cut with a cryostat
and mounted on glass slides coated with poly-L-lysine (Polysciences, Warrington,
Pa.). Frozen sections were fixed in cold acetone for 10 min, air dried, and probed
with immunoglobulin G (IgG) monoclonal antibodies (MAbs) that bound to pig
immune cells (VMRD, Pullman, Wash.) or H. ducreyi. Antibody binding was
detected with the ABC peroxidase kit (Vector Labs, Burlingame, Calif.) and
diaminobenzidine as a substrate after a blocking step with 5% normal horse
serum plus 5% normal pig serum. Samples were counterstained with Giemsa. T
cells were detected with MAb PG114A that recognizes porcine CD5. MAb
DH59B binds to glycolipid GM1 on the surface of porcine and human macro-
phages and granulocytes. Swine polymorphonuclear leukocytes (PMNs) and
macrophages bound DH59B and were distinguishable on the basis of nuclear
morphology. MAb PIg45A was used to detect surface IgM on B cells; MAb
MSA3 recognizes the porcine equivalent of the major histocompatibility complex
(MHC) class II HLA-DR marker (36). MAbs 2C7 (51) and 5C9 (8) bind H.
ducreyi outer membrane proteins (OMPs) and were kindly provided by Stanley
Spinola. Omission of primary antibodies from tissue staining and antibody bind-
ing to freshly isolated pig peripheral blood lymphocytes served as negative and
positive controls, respectively.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western
blot (immunoblot) analysis. H. ducreyi whole-cell sonicates were solubilized in
Laemmli solubilizing buffer, and proteins were electrophoresed from a single
preparative well in a 15% polyacrylamide gel. Prestained molecular weight mark-
ers were from Gibco-BRL (Gaithersburg, Md.). Separated proteins were trans-
ferred to BA-S nitrocellulose membrane (Schleicher & Schuell, Inc., Keene,
N.H.). Membrane strips were cut and probed with pig serum (1:250, 1:500, or
1:1,000), MAb 2C7 (hybridoma culture supernatant; 1:10), or MAb 5C9 (ascites,
1:20,000) after blocking with 2% skim milk powder in PBS containing 0.01%
Tween 20. Primary antibody binding was visualized with horseradish peroxidase-
conjugated rabbit anti-pig or goat anti-mouse IgG (Sigma Chemical Co., St.
Louis, Mo.) and the enhanced chemiluminescent detection system (ECL; Am-
ersham, Arlington Heights, Ill.).
RESULTS
Lesion development.We inoculated the dorsal surface of the
ears of four Yorkshire Cross and two Landrace pigs with ap-
proximately 107 CFU of live or heat-killed H. ducreyi 35000
delivered with the Multi-Test allergy testing device as de-
scribed in Materials and Methods. The imprint of the delivery
device was evident at all sites immediately after application,
and 24 h after inoculation, all sites were erythematous. We had
conducted preliminary studies with the Multi-Test applicator
loaded with PBS, into which wooden applicator sticks, scraped
across sterile chocolate agar plates, had been swirled, to test
for nonspecific inflammation produced by our inoculation pro-
cedure. Aside from the imprint of the delivery device imme-
diately after application, there was no visible reaction to this
procedure. We did not examine these sites histologically. Pap-
ules developed by 48 h at sites inoculated with live H. ducreyi.
Occasionally, small papules were observed at 48 h at sites that
received heat-killed inocula; these were visible only microscop-
ically and were not accompanied by the histological changes
described below for sites with live H. ducreyi organisms. Lesion
development beyond 48 h occurred only at sites with live bac-
teria. Seven days after inoculation, individual pustules result-
ing from H. ducreyi delivered by the nine individual tines of the
delivery device had coalesced into circular lesions approxi-
mately 5 mm in diameter. In contrast, sites inoculated with
heat-killed bacteria were not measurable and were barely vis-
ible on day 7. By 14 days, the lesions were ulcerated, as defined
by the complete erosion of the epidermis, with raised borders
and a dry, crusty appearance. Figure 1 shows typical 18-day
lesions on the ears of a Landrace pig. Lesions persisted for at
least 21 days on the ears of Yorkshire pigs and 28 days on the
Landrace animals but never developed into the exudative,
open sores characteristic of human chancroidal ulcers. Reso-
lution of ear lesions did not occur within the 4-week time frame
of these experiments.
We also inoculated the skin of the backs of 11 Yorkshire and
2 Landrace pigs exactly as described above. Lesion develop-
ment at core body sites was more variable than that of ear
lesions. The duration of back lesions ranged from 2 to 11 days
(mean 6 standard deviation, 5.5 6 3.5 days). Of 10 back
lesions examined histologically, only 2 had progressed beyond
the pustule stage, and a single sample showed complete epi-
dermal erosion. Thus, live H. ducreyi consistently caused ulcer
development when inoculated onto the ears but not the backs
of domestic swine.
Recovery of H. ducreyi from lesions. Four biopsy samples
from ear sites inoculated with live H. ducreyi were cultured;
three were positive (days 2, 14, and 17), and one was negative
(day 7). H. ducreyi was isolated from four of five cultured
biopsy samples from back sites inoculated with live organisms.
Positive samples were obtained on days 1 (two independent
samples), 4, and 11, and the negative culture was obtained on
day 4. H. ducreyi was never recovered from biopsy sites that
received heat-killed bacteria. Unidentified microbial skin con-
taminants were present consistently on recovery plates without
vancomycin from both live and heat-killed samples; however,
skin flora were not overgrown, and H. ducreyi was clearly not
present in negative cultures.H. ducreyi isolated on nonselective
media was confirmed by growth of subcultures on plates con-
taining 3 mg of vancomycin per ml.
Histopathology of lesions. Figure 2A shows the histological
presentation of normal porcine ear skin. The earliest biopsies
of experimental infections on pig ears were done 2 or 4 days
after inoculation, when lesions were clearly visible at sites that
had received live H. ducreyi but not heat-killed bacteria. At
these time points, papules containing PMNs were present con-
sistently and confined to the upper layers of the epidermis in
biopsy samples from pigs that had received live inocula and
were sometimes present in samples from pigs that had received
heat-killed inocula (Fig. 2B and C). The papule in Fig. 2C was
sectioned near the center of the biopsy sample, making it
FIG. 1. Landrace pig ear inoculated with H. ducreyi 35000. Eighteen-day-old
lesions resulting from inoculation of ;107 CFU of live H. ducreyi bacteria are
visible. Six individual inocula were delivered through abrasions in the epidermis
with an allergen-testing device.
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appear larger than the one in Fig. 2B, which was cut nearer the
edge of the biopsy sample. Extensive thickening of the epider-
mis was noted only in biopsy samples taken from sites inocu-
lated with live H. ducreyi organisms. While heat-killed bacteria
produced a modest inflammatory response at these early times,
the perivascular and interstitial infiltrate was more vigorous in
response to live inocula.
Biopsy samples of ear lesions taken 1 week after inoculation
with live H. ducreyi contained excessive keratotic layers inter-
laced with PMNs in the epithelium accompanied by marked
hyperplasia and acanthosis of the adjacent epidermis (Fig. 2D).
When present, the underlying basal keratinocytes were disor-
ganized and interspersed with inflammatory cells beneath the
lesion (Fig. 2E). Complete erosion of the squamous epithelium
FIG. 2. Histologic appearance of normal and H. ducreyi-infected Yorkshire Cross pig ear skin. (A) Uninfected ear skin. (B and C) Lesions 4 days after inoculation
with live (B) or heat-killed (C) H. ducreyi 35000. The pustule separation from the epidermis is a sectioning artifact. Epidermal thickening was noted only in biopsy
samples from sites that received a live challenge (compare panels A, B, and C; H&E stain; magnification, 360). (D and E) Ear lesions 1 week after inoculation with
live H. ducreyi 35000 characterized by marked changes in the epidermis. Note the extensive thickening and plasticity of the epidermis in panel D. (H&E stain;
magnification, 360). The squamous epithelium beneath the intraepidermal lesion was disorganized and nearly eroded, and inflammatory cells had accumulated in the
interstitial spaces below the lesion (E) (H&E stain; magnification, 3210). (F) Ear lesions 2 weeks after inoculation with live H. ducreyi 35000. Most of the squamous
epithelium was replaced by PMNs in fibrin and cellular debris (H&E stain; magnification, 3210). The separation between the necrotic material and the dermis is an
artifact of sectioning. Note the complete destruction of the epidermis beneath the lesion.
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was sometimes seen at this time point. We saw increased
perivascular and interstitial accumulation of inflammatory cells
in the dermis in comparison with that in younger lesions. Mi-
cropapules resulting from inoculation with heat-killed H. du-
creyi were resolved by 1 week, and there was no further influx
of inflammatory cells in the dermis (data not shown).
An ear biopsy sample taken 2 weeks after inoculation with
live H. ducreyi (Fig. 2F) showed complete destruction of the
epidermis beneath the lesion. The mononuclear infiltrate di-
rectly beneath the ulcer contained some histiocytes, but we
were unable to locate intra- or extracellular bacteria in biopsy
material with Giemsa or Warthin-Starry stain or immunoper-
oxidase staining with MAbs recognizing H. ducreyi surface pro-
teins.
Figure 3 shows a rare but well-developed lesion 11 days after
inoculation of back skin with H. ducreyi. In contrast to ear
biopsy samples, from which we obtained only epidermis and
the upper portion of the dermis to avoid completely piercing
the pig ears, we obtained a full-thickness biopsy sample from
this back lesion demonstrating the three classical histopatho-
logic zones associated with human chancroid (15, 34, 48).
To determine the pig immune cell types involved in the host
response to H. ducreyi infection, we used MAbs against swine
lymphocyte markers for immunoperoxidase staining of sam-
ples taken 1 week after inoculation. GM1, a glycolipid ex-
pressed on swine and human granulocytes and macrophages,
was present on cells in the inflammatory infiltrate (Fig. 4A)
and on the PMNs within the intraepidermal lesion (data not
shown). T cells were identified in the infiltrate by the CD5
marker (Fig. 4B). No immunoperoxidase staining was observed
in the absence of primary antibody (data not shown). An MHC
class II marker (MSA3) recognizing the porcine equivalent of
the HLA-DR antigen stained epidermal dendritic cells but not
the mononuclear inflammatory cells present in the dermal
infiltrate (data not shown). We used an anti-IgM MAb in an
effort to determine if B cells were present in biopsy samples;
however, this reagent produced high background staining
throughout the dermis, making identification of surface IgM-
bearing cells impossible. Thus, although we cannot comment
on the presence or absence of B cells, the cellular inflammatory
response of pigs to H. ducreyi infection included T cells, mac-
rophages, and granulocytes.
Serologic response and lack of immunity to repeat chal-
lenge. Pooled normal pig serum (NPS) and serum collected
from two infected animals 11 or 17 days after inoculation were
used to probe Western blots of H. ducreyi 35000 proteins. All
swine serum samples contained IgG antibodies that reacted
with multiple bacterial proteins in whole-cell lysates, including
a doublet that comigrated with two MAb 2C7-reactive bands
(Fig. 5). MAb 2C7 binds the 39- to 42-kDa major OMP
(MOMP) of H. ducreyi and other members of the family Pas-
teurellaceae; purified MOMP preparations contain multiple
bands representing different conformations of the protein (51).
Reactivities to the bands comigrating with the MOMP were
similar in NPS and the serum from one infected pig (Fig. 5,
lanes 3 and 4); however, reactivity for the doublet in 11-day
serum from another infected pig was present at roughly a
four-fold-higher titer than that of NPS (Fig. 5, lanes 2 and 5).
Sera from both infected pigs, but not NPS, recognized a pro-
tein that comigrated with the H. ducreyi-specific 28-kDa OMP
recognized by MAb 5C9 (8). The relative sizes of other bacte-
rial proteins recognized by sera from infected pigs, but not
NPS, are indicated in Fig. 5.
Two pigs, originally infected on the back, were reinoculated
with live and heat-killed H. ducreyi 35000. One animal received
the second infection at new sites on the back 27 days after the
initial challenge, and the second pig was reinoculated on the
ear 17 days after primary infection. Lesion development on the
FIG. 3. Histologic appearance of a rare H. ducreyi lesion in Yorkshire Cross
pig back skin 11 days after inoculation. This full-thickness biopsy sample shows
three zones beneath the lesion: a narrow superficial zone containing necrotic
tissue, PMNs, and fibrin (A); a broader middle zone characterized by inflamed
tissue and a perivascular infiltrate (B); and a deep zone with a more diffuse
infiltrate and thick-walled vessels (C). The separation between the superficial
and middle zones is an artifact of sectioning. H&E stain; magnification, 330.
FIG. 4. Immunoperoxidase staining of the perivascular infiltrate beneath an
ear lesion 1 week after inoculation with live H. ducreyi bacteria. (A) Glycolipid
GM1 on macrophages and granulocytes was stained with MAb DH59B; (B) CD5
on T cells was identified with MAb PG114A (B). Giemsa counterstain; magni-
fication, 3210.
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back following repeat challenge with live H. ducreyi 35000 was
indistinguishable from that from the original course of infec-
tion in that animal (data not shown). Ear lesions in the other
pig were equivalent to those that developed on the ears of
animals that received the same inoculum but had not been
previously infected. While we did not examine biopsy material
from lesions resulting from second infections, the ear sites
were visually more dramatic than the original lesions on the
back (data not shown). Thus, although infection withH. ducreyi
resulted in increased serum IgG antibodies to bacterial anti-
gens, pigs did not develop immunity to subsequent challenge
with the same strain.
DISCUSSION
Experimental infection of domestic swine with H. ducreyi
shares many clinical and histologic features with experimental
human infection (52) and human chancroid disease. Following
inoculation of live bacteria designed to simulate the natural
route of infection through breaks in the epithelium, persistent
lesions developed, from pustules to ulcers, containing a super-
ficial zone of PMNs and extracellular debris accompanied by a
perivascular and interstitial dermal infiltrate of T cells and
macrophages. It is notable that while full lesion development
did not occur following inoculation of heat-killed bacteria, a
mild inflammatory response was observed at these sites. This
attenuated host response may have been elicited by heat-stable
bacterial components, such as lipo-oligosaccharide, present in
the heat-killed inocula.
Experimental ulcers had raised, erythematous margins but
never became soft or exudative, like chancroid lesions in hu-
mans. This result may reflect differences in host tissue re-
sponses or local parameters such as temperature, skin thick-
ness, innervation, or vascularization, for which human genital
skin and porcine ear skin likely differ. Indeed, inoculating pig
backs, sites with thicker, less vascular, and warmer skin than
the ears, resulted in less-consistent lesion development and
generally reduced lesion duration. Furthermore, H. ducreyi
delivered to the skin of the inner thigh of two pigs (a location
approximating swine core body temperature of ;388C) failed
to produce any evidence of lesion development (data not
shown), consistent with the sensitivity of this organism to tem-
peratures exceeding 358C. Whereas the temperature of pig
ears may have been reduced sufficiently to allow ulcer devel-
opment, temperature and other differences between human
genital epithelia and pig ears may have contributed to the
atypical outward appearance of experimentalH. ducreyi lesions
in swine.
The dose of H. ducreyi required to cause chancroid in nat-
ural sexually transmitted infection is not known. Because H.
ducreyi bacteria adhere tightly to one another and to many
surfaces (1, 15, 30), including the Multi-Test Applicator used
in our inoculation procedure, it is difficult to determine the
actual dose delivered to swine skin in our experiments. Al-
though we loaded approximately 107 CFU of H. ducreyi onto
the tines of the delivery device, undoubtedly only a portion of
these bacteria penetrated the epidermis during inoculation.
Studies using radiolabeled tuberculin suggest that the Multi-
Test Applicator reproducibly delivers 0.2 to 0.5% of a solution
loaded onto the tines (19a). Therefore, our inoculating dose
may have been as low as 104 CFU. Lesions in the recently
described chilled rabbit (41) and primate (53) models of H.
ducreyi infection resulted from intradermal injection of ;105
CFU or between 107 and 108 CFU, respectively. Spinola et al.
used the Multi-Test Applicator to inoculate the arms of the
volunteers in recent human challenge studies (52) in which
lesions developed from 104 to 106 CFU of H. ducreyi 35000
loaded onto the tines of the device. As few as 20 to 2,000 CFU
of H. ducreyi may have initiated lesion development in that
model. While we have not yet determined the minimum dose
required to produce ulcers in the swine model, the inocula
used in these pilot experiments were probably higher by an
order of magnitude than those used in experimental human
infection. Future experiments using lower challenge doses of
H. ducreyi in pigs will provide a better basis for comparison of
the numbers of H. ducreyi required for early lesion develop-
ment and formation of persistent ulcers in the various available
models.
We recovered H. ducreyi from pig lesions up to 17 days after
inoculation of ears and 11 days after inoculation of back skin.
We did not attempt to quantitate recovered bacteria, and given
the difficulties in determining the numbers of H. ducreyi bac-
teria present in the skin immediately after inoculation, we
cannot be certain that active bacterial replication occurred in
the lesions. However, the presence of viableH. ducreyi in ulcers
more than 2 weeks postinoculation, in the face of an inflam-
matory host response, suggests that the bacteria were capable
of responding to environmental signals and expressing viru-
lence determinants necessary for survival under those condi-
tions. The fact that viable bacteria were required for lesion
development is further illustrated by the failure of heat-killed
H. ducreyi to produce ulcers in the swine model.
An advantage of the pig model and the use of the Multi-Test
device for inoculation is the ability to simultaneously deliver
multiple different inocula to the same animal host. The shaved
backs of pigs easily accommodated up to 32 individual samples.
Preliminary experiments were performed with two recent
(1992 and 1993) clinical isolates from chancroid patients in
Malawi and CIP542 (ATCC 33940), an isolate previously char-
acterized as less virulent in an early rabbit model of H. ducreyi
infection (18). The two independent clinical isolates produced
lesions grossly equivalent to those formed by H. ducreyi 35000,
whereas CIP542 produced lesions markedly less severe than
those of H. ducreyi 35000, Thus, even though the lesions were
less dramatic on the back than on the ear, lesion development
FIG. 5. Serologic response of Yorkshire Cross pigs to H. ducreyi infection. A
Western blot of H. ducreyi 35000 whole-cell proteins probed with MAb 5C9 (lane
1), NPS diluted 1:250 (lane 2) or 1:1,000 (lane 3), serum collected from two pigs
17 (lane 4) or 11 (lane 5) days after infection, each diluted 1:1,000, and MAb 2C7
(lane 6) is shown. Size markers are indicated on the left, and the positions of two
H. ducreyi OMPs are indicated on the right. The arrowheads mark unidentified
H. ducreyi proteins recognized by IgG antibodies in serum from infected pigs but
not in NPS.
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on the back was sufficient to distinguish between isolates dif-
fering in virulence properties. The extent of immune interac-
tions between individual lesions has not been determined and
is of some concern for comparisons of different inocula, par-
ticularly when isolates appear to elicit similar lesions. Never-
theless, reduced lesion development in this model, such as that
which we observed with CIP542, is a potential indicator of
reduced virulence. We hasten to point out that CIP542 is not
completely avirulent, since it was originally a clinical isolate
and has been shown recently to initiate ulcer formation upon
accidental inoculation into human skin (54). However, others
have demonstrated differences between CIP542 and more vir-
ulent strains, including H. ducreyi 35000, in an OMP profile
(50) and in vitro cytotoxic activity against human fibroblasts
(22), supporting its characterization as relatively less virulent
than H. ducreyi 35000.
Even on pig ears, where lesions were more severe and per-
sistent than on backs, we were able to deliver up to six indi-
vidual inocula to each ear of the Yorkshire pigs and eight or
more separate samples per ear of the Landrace pigs. In fact,
the latter breed was chosen in part because they have larger
ears than other pig breeds. In addition, the use of purebred
pigs may reduce individual variation in the host immune re-
sponse to H. ducreyi, providing a better standard for compar-
ison between experiments using different inocula. Screening
numerous H. ducreyi mutants or biological variants first on pig
backs, followed by characterization of potentially interesting
individual isolates on pig ears, may provide an efficient proto-
col for identification of bacterial virulence characteristics.
The histologic features of ulcers caused by H. ducreyi in
swine were similar in many respects to those reported by Pur-
cell et al. in rabbits housed at reduced temperatures (41), by
Spinola et al. in volunteers (52), and, most recently, by Totten
et al. in nonhuman primates (53). All of these models of
infection result in intraepidermal lesions containing PMNs and
a perivascular and interstitial accumulation of inflammatory
cells, typical of human chancroid lesions. Using commercially
available MAbs to pig immune cells, we were able to identify T
cells, macrophages, and granulocytes among the infiltrating
cells in the dermis beneath lesions in swine, consistent with
observations from the human challenge study (52). Human
inflammatory cells and keratinocytes examined in 3-day lesions
also expressed the MHC class II HLA-DR antigen, whereas
pig cells responding toH. ducreyi at day 7 did not. It is not clear
whether this observation represents a fundamental difference
between swine and human responses to H. ducreyi or is a
consequence of the different stages of lesion development ex-
amined. Our initial antibody panel included the single MAb
directed against the swine lymphocyte DR antigen; it is possi-
ble that other MHC class II antigens are expressed by pig cells
in response to H. ducreyi infection. MAbs recognizing the por-
cine equivalents of HLA-DP and -DQ are available and will be
used to better characterize the kinetics of the swine immune
response to chancroid.
It is interesting that the swine T-cell population is unique
regarding the expression of CD4 and CD8 antigens in circu-
lating and tissue pools. In addition to the classical CD41 CD82
T-helper and CD42 CD81 cytolytic T cells, pigs have unusual
extrathymic CD42 CD82 and CD41 CD81 subsets (43, 44,
47). Most of the so-called double-negative cells express the gd
TCR (20, 21, 45), and the double-positive cells constitutively
express the MHC class II DR antigen (46). The specific func-
tions of the CD42 CD82 and CD41 CD81 porcine T cells are
unknown. The CD5 antigen is expressed on most swine T cells
(4, 43), and immunoperoxidase staining with this marker iden-
tified many inflammatory cells in pig lesions caused by H.
ducreyi (Fig. 3). Antibodies to porcine CD4, CD8, and gd TCR
markers are available, and we are currently using these re-
agents to further characterize the swine T-cell response to H.
ducreyi infection. Preliminary observations suggest that both
CD41 and CD81 pig cells are present in 7-day lesions, whereas
gd TCR1 cells are rare. The experiments described in this
report demonstrate the ability to characterize the porcine cel-
lular immune response toH. ducreyi infection and ultimately to
compare this response with that of humans.
NPS contained IgG antibodies that bound H. ducreyi whole-
cell lysates; this may represent cross-reactivity of preexisting
antibodies with antigens on other members of the Pasteurel-
laceae (9, 16, 51), several of which are common among swine
herds (7, 17, 24, 33). Using Western blot analysis with sera
from two H. ducreyi-infected pigs, we detected an increase in
IgG antibodies to a protein comigrating with the H. ducreyi-
specific 28-kDa OMP, and reactivity to proteins comigrating
with the H. ducreyiMOMP was elevated in the serum from one
infected animal. The role of humoral immune responses in
chancroid is unclear. Several studies have shown that sera from
chancroid patients have higher levels of antibody to H. ducreyi
antigens than sera from controls without a history of chancroid
(2, 35). It is difficult to compare the magnitude of the increased
IgG reactivity we observed in Western blots with unadsorbed
swine sera with published data from preadsorbed patient sera
in solid-phase assays. However, the higher IgG titers in sera
from infected swine against several H. ducreyi antigens are
consistent with clinical data. Despite the increased antibody
levels, we saw no evidence of protective immunity in pigs
following repeated challenge withH. ducreyi. This is in contrast
to the measure of protective immunity developed by rabbits
after infection or immunization (19). The occurrence of re-
peated chancroid infections in human populations suggests
that broadly protective immunity does not result fromH. ducreyi
infection. This lack of protective immunity was substantiated in
rechallenge studies performed with human volunteers (52).
In conclusion, we have described a swine model of infection
with H. ducreyi that resembles natural and experimental hu-
man infection. Advantages of this model include the use of
ambient animal housing temperatures, a relevant route of in-
oculation, and lower purchase and housing costs for pigs than
for primates. In addition, multiple bacterial strains, including
antibiotic-resistant mutants, can be used to infect an individual
animal, providing an effective means of comparing differences
in virulence. We anticipate that this model will serve as a
valuable tool in understanding H. ducreyi pathogenesis and
host cellular immune responses involved in chancroid.
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